https://www.selleckchem.com/pr....oducts/8-oh-dpat-8-h
Corneal graft rejection may be successfully managed with corticosteroid therapy. However, constant vigilance and follow-up are advised because of the risk of recurrence in case of continued pembrolizumab treatment. Given the subclinical presentation, baseline ophthalmological screening is advised in all corneal graft patients after initiating immune checkpoint inhibitor therapy.Purpose To evaluate the association of scleral contact lens (SCL) use on the risk for keratoplasty for people with keratoconus. Methods The elec
Like
Comment
Share
